SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-407915
Filing Date
2015-12-18
Accepted
2015-12-18 17:25:00
Documents
5
Period of Report
2015-12-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d64029d8k.htm 8-K 17503
2 EX-10.1 d64029dex101.htm EX-10.1 14529
3 EX-99.1 d64029dex991.htm EX-99.1 567121
4 GRAPHIC g64029g31t06.jpg GRAPHIC 36475
5 GRAPHIC g64029g43y20.jpg GRAPHIC 64859
  Complete submission text file 0001193125-15-407915.txt   740187
Mailing Address 2656 CROSSPARK ROAD, SUITE 100 CORALVILLE IA 52241
Business Address 2656 CROSSPARK ROAD, SUITE 100 CORALVILLE IA 52241 319-665-2575
KEMPHARM, INC (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36913 | Film No.: 151297670
SIC: 2834 Pharmaceutical Preparations